These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32829664)

  • 21. Structural Perspectives on the Mechanism of Soluble Guanylate Cyclase Activation.
    Wittenborn EC; Marletta MA
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice.
    Pradhan K; Sydykov A; Tian X; Mamazhakypov A; Neupane B; Luitel H; Weissmann N; Seeger W; Grimminger F; Kretschmer A; Stasch JP; Ghofrani HA; Schermuly RT
    Int J Cardiol; 2016 Aug; 216():85-91. PubMed ID: 27140341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is next in nitric oxide research? From cardiovascular system to cancer biology.
    Bian K; Murad F
    Nitric Oxide; 2014 Dec; 43():3-7. PubMed ID: 25153032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.
    Breitenstein S; Roessig L; Sandner P; Lewis KS
    Handb Exp Pharmacol; 2017; 243():225-247. PubMed ID: 27900610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide/soluble guanylyl cyclase signaling mediates depolarization-induced protection of rat mesencephalic dopaminergic neurons from MPP⁺ cytotoxicity.
    Kurauchi Y; Hisatsune A; Isohama Y; Sawa T; Akaike T; Katsuki H
    Neuroscience; 2013 Feb; 231():206-15. PubMed ID: 23238575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted genomic disruption of h-ras induces hypotension through a NO-cGMP-PKG pathway-dependent mechanism.
    Chamorro-Jorganes A; Grande MT; Herranz B; Jerkic M; Griera M; Gonzalez-Nuñez M; Santos E; Rodriguez-Puyol D; Lopez-Novoa JM; Rodriguez-Puyol M
    Hypertension; 2010 Sep; 56(3):484-9. PubMed ID: 20679183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel approaches and opportunities for cardioprotective signaling through 3',5'-cyclic guanosine monophosphate manipulation.
    Bice JS; Burley DS; Baxter GF
    J Cardiovasc Pharmacol Ther; 2014 May; 19(3):269-82. PubMed ID: 24572031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of nitric oxide-sensitive guanylyl cyclase.
    Friebe A; Koesling D
    Circ Res; 2003 Jul; 93(2):96-105. PubMed ID: 12881475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
    Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
    World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systems Pharmacology and Rational Polypharmacy: Nitric Oxide-Cyclic GMP Signaling Pathway as an Illustrative Example and Derivation of the General Case.
    Garmaroudi FS; Handy DE; Liu YY; Loscalzo J
    PLoS Comput Biol; 2016 Mar; 12(3):e1004822. PubMed ID: 26985825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.
    Mollnau H; Wendt M; Szöcs K; Lassègue B; Schulz E; Oelze M; Li H; Bodenschatz M; August M; Kleschyov AL; Tsilimingas N; Walter U; Förstermann U; Meinertz T; Griendling K; Münzel T
    Circ Res; 2002 Mar; 90(4):E58-65. PubMed ID: 11884382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioactive Catalytic Nanocompartments Integrated into Cell Physiology and Their Amplification of a Native Signaling Cascade.
    Belluati A; Craciun I; Palivan CG
    ACS Nano; 2020 Sep; 14(9):12101-12112. PubMed ID: 32869973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The alpha2beta1 isoform of guanylyl cyclase mediates plasma membrane localized nitric oxide signalling.
    Bellingham M; Evans TJ
    Cell Signal; 2007 Oct; 19(10):2183-93. PubMed ID: 17643962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbon monoxide: an endogenous modulator of the nitric oxide-cyclic GMP signaling system.
    Ingi T; Cheng J; Ronnett GV
    Neuron; 1996 Apr; 16(4):835-42. PubMed ID: 8608001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric-oxide-dependent activation of pig oocytes: the role of the cGMP-signalling pathway.
    Petr J; Rajmon R; Chmelíková E; Tománek M; Lánská V; Pribánová M; Jílek F
    Zygote; 2006 Feb; 14(1):9-16. PubMed ID: 16700970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide and cyclic GMP are involved in angiotensin II AT(2) receptor effects on neurite outgrowth in NG108-15 cells.
    Gendron L; Côté F; Payet MD; Gallo-Payet N
    Neuroendocrinology; 2002 Jan; 75(1):70-81. PubMed ID: 11810036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide/cyclic guanosine monophosphate signaling in the central complex of the grasshopper brain inhibits singing behavior.
    Wenzel B; Kunst M; Günther C; Ganter GK; Lakes-Harlan R; Elsner N; Heinrich R
    J Comp Neurol; 2005 Jul; 488(2):129-39. PubMed ID: 15924338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic guanosine monophosphate in the regulation of the cell function.
    Zbrojkiewicz M; Śliwiński L
    Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1276-1285. PubMed ID: 28026830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of nitric oxide signaling pathways in the mouse retina.
    Blom J; Giove T; Deshpande M; Eldred WD
    J Comp Neurol; 2012 Dec; 520(18):4204-17. PubMed ID: 22592770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.